World Journal of Gastrointestinal Pathophysiology

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 40

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

106

HTML

2709

Sum=2815

Publishing Process of This Article

Item

Count

Browse

Download

345

Sum=430

Oct 28, 2024 (publication date) through Oct 26, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Zhang H, Dong X, Zhu L, Tang FS. Elafibranor: A promising treatment for alcoholic liver disease, metabolic-associated fatty liver disease, and cholestatic liver disease. World J Gastroenterol 2024; 30(40): 4393-4398 [PMID: 39494094 DOI: 10.3748/wjg.v30.i40.4393]
URL:	https://www.wjgnet.com/2150-5330/full/v30/i40/4393.htm

Number	Citing Articles